Nicola Wake, Associate Director, Medicines Use and Safety at SPS, presents a summary of the resources published by SPS between 20th and 26th September.

To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.

Quick links to highlighted resources:

The licence and supporting evidence for aflibercept biosimilars – log in required

Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.

https://www.sps.nhs.uk/articles/the-licence-and-supporting-evidence-for-aflibercept-biosimilars/

Preparing to use aflibercept 2mg biosimilar

Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.

https://www.sps.nhs.uk/articles/preparing-to-use-aflibercept-2mg-biosimilar/

Rarely used medicines – how to view them on RxInfo

A guide to support on-call staff in locating supplies of rarely used medicines out of hours.

https://www.sps.nhs.uk/articles/rarely-used-medicines-how-to-view-them-on-rxinfo/

Medicines Monitoring Tool

Updated entry for acetylcholinesterase inhibitor

https://www.sps.nhs.uk/home/tools/drug-monitoring/

Next events – forthcoming webinars and conferences

https://www.sps.nhs.uk/home/events/next-events/

Podcast description:

NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.